Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study (Q41904942)
Jump to navigation
Jump to search
scientific article published on 25 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study |
scientific article published on 25 February 2011 |
Statements
1 reference
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study (English)
1 reference
Karim Fizazi
1 reference
Michael Carducci
1 reference
Matthew Smith
1 reference
Ronaldo Damião
1 reference
Janet Brown
1 reference
Lawrence Karsh
1 reference
Piotr Milecki
1 reference
Neal Shore
1 reference
Michael Rader
1 reference
Huei Wang
1 reference
Qi Jiang
1 reference
Sylvia Tadros
1 reference
Roger Dansey
1 reference
Carsten Goessl
1 reference
25 February 2011
1 reference
1 reference
377
1 reference
9768
1 reference
813-822
1 reference
Identifiers
1 reference
1 reference
1 reference